CDC updates guidance on retesting children who received recalled blood lead tests
The Centers for Disease Control and Prevention Friday updated its recommendations for clinicians retesting children tested with recalled LeadCare lead test kits. The Food and Drug Administration and Magellan Diagnostics recently expanded their Class 1 recall of the LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests due to a risk for falsely low results.
Related News Articles
Headline
A recent opinion piece in The Hill promoting physician-owned hospitals gives a misleading and incomplete account of these facilities and the reasons for…
Blog
A recent piece in The Hill promoting physician-owned hospitals gives a misleading and incomplete account of these facilities and the reasons for current…
Headline
The Centers for Medicare & Medicaid Services late today released its calendar year 2022 final rule for the physician fee schedule. The rule cuts the…
Headline
Commenting today on the Centers for Medicare & Medicaid Services’ physician fee schedule rule for calendar year 2022, the AHA expressed appreciation…
Headline
The Centers for Medicare & Medicaid Services late today released its calendar year 2022 proposed rule for the physician fee schedule. The rule proposes to…
Headline
A recent Health Affairs Blog post by physicians “gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill…